Lifeward
Marlborough, Massachusetts, United States · Biotechnology, Health Care, Medical
Lifeward is a medical device manufacturer specializing in mobility-related solutions. Their products include the ReWalk Personal Exoskeleton and AlterG Anti-Gravity Systems. Lifeward is dedicated to helping individuals with physical limitations regain mobility. The company is involved in groundbreaking technologies to enhance treatment methodologies.
Key facts
- Headquarters
- Marlborough, Massachusetts, United States
- Employees
- 80
- Industries
- Biotechnology, Health Care, Medical
- Status
- Public (LFWD)
- Website
- golifeward.com
- Company page
Recent activity at Lifeward
- : Lifeward Ltd. Appoints Ronen Tsimerman as Chief Financial Officer
- : SEC 8-K (5.02): On October 26, 2026, Lifeward Ltd. appointed Ronen Tsimerman as the Chief Financial Officer (CFO), effective November 1, 2026. Mr. Tsimerman, aged 56, has extensive experience in global finance, previously serving as CFO of Scopio Labs Ltd. and IceCure Medical Ltd. His employment agreement includes a monthly salary of NIS 70,000, performance-based bonuses, and a 3-month notice period for termination, which extends to 4 months upon a change in the CEO. This appointment is subject to shareholder approval at the annual meeting on October 30, 2026, concerning the company's renewed compensation policy.
- : SEC 8-K (5.02): On October 4, 2026, Rami Aviram informed Lifeward Ltd. that he will not join the Company as the Chief Financial Officer, a role he was set to assume effective November 1, 2026. Consequently, Josh Hexter will continue as the interim principal financial officer and principal accounting officer without additional compensation while the Company searches for a permanent successor. The ongoing search for a new Chief Financial Officer emphasizes the Company's need to fill this critical role after Aviram's withdrawal.
- : Lifeward Ltd. Appoints Josh Hexter as Interim Principal Financial Officer
- : SEC 8-K (5.02): Lifeward Ltd. reported the departure of Almog Adar as Chief Financial Officer, effective September 30, 2026. Following his departure, Josh Hexter has been designated as the interim principal financial officer and principal accounting officer, effective October 1, 2026. Hexter, who is also the Interim Chief Executive Officer, will hold this position until November 1, 2026, when Rami Aviram is set to be appointed as the new Chief Financial Officer. This change is significant for the company's leadership structure and financial oversight.
- : SEC 8-K (7.01): On September 8, 2026, Lifeward Ltd. disclosed an investor presentation on its website, intending to use it in discussions with analysts, potential investors, and other interested parties. The presentation is classified as Item 7.01 under Regulation FD, which is pertinent for disclosures made to ensure fair communication with investors. This proactive communication strategy is aimed at enhancing transparency and potentially attracting new investment interest. The company has included the presentation as Exhibit 99.1 with this filing.
- : Lifeward Appoints Josh Hexter as Interim Chief Executive Officer
- : Lifeward Ltd. Announces CEO Mark Grant's Departure
- : SEC 8-K (5.02): Effective August 31, 2026, Mr. Mark Grant will depart as President and Chief Executive Officer of Lifeward Ltd. and as a member of the Board of Directors. This departure followed the Company's entry into a separation agreement with Mr. Grant on the same date. Notably, his departure was not the result of any disagreements with the Company. To ensure a smooth transition, a consulting agreement will commence on September 1, 2026, allowing Mr. Grant to assist the Company in this transition period.
- : SEC 8-K (5.02): On August 20, 2026, Lifeward Ltd. appointed Avraham Gabay as a Class III Director and Chair of the Board, effective immediately. This follows the earlier appointments of Yonason Greenwald and Haggai Zamir as Class III Directors on August 14, 2026. Each appointed director will serve until the 2026 Annual Meeting of Shareholders and receive standard compensation as specified in the Company's annual report. Additionally, on August 20, Nadav Kidron resigned from the Board effective immediately without any disagreements with the Company. These changes in the Board enhance the Company's governance structure and leadership as it prepares for the upcoming shareholder meeting.
Lifeward funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2026 | Venture | $11.2M |
| Apr 2026 | Venture | $20.0M |
| Jan 2025 | Venture | $5.0M |
| Oct 2021 | Venture | $16.3M |
| Feb 2021 | Venture | $40.0M |
Leadership
- Larry Jasinski, Executive Officer, Director
- Jeff Dykan, Director
- Yohanan Engelhardt, Director
- John Poduska, Director
- Wayne Weisman, Director
- Yasushi Ichiki, Director
- Arik Dan, Director
- Randel Richner, Director
Verified email and direct lines for Lifeward’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Lifeward files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Lifeward in the news
- Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders - Yahoo Finance (Dec 27, 2024)
- Rehabilitation Exoskeletons Market : Global Industry Analysis and Opportunity Assessment, 2036 - Future Market Insights (Jul 25, 2026)
- Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton - GlobeNewswire (Sep 15, 2026)
- Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer - GlobeNewswire (Aug 31, 2026)
- Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026 - GlobeNewswire (Aug 07, 2026)
Companies similar to Lifeward
- careviso (Formerly CMT Solutions) · Biotechnology, Health Care, Medical
- Microba Life Sciences Limited · Biotechnology, Health Care, Medical
- i'SUPPLY · Biotechnology, Health Care, Medical
- Los Angeles Cancer Network · Biotechnology, Health Care, Medical
- Ixico PLC · Biotechnology, Health Care, Medical
About Lifeward: questions and answers
What does Lifeward do?
Lifeward is a medical device manufacturer specializing in mobility-related solutions. Their products include the ReWalk Personal Exoskeleton and AlterG Anti-Gravity Systems. Lifeward is dedicated to helping individuals with physical limitations regain mobility. The company is involved in groundbreaking technologies to enhance treatment methodologies.
Where is Lifeward headquartered?
Lifeward is headquartered in Marlborough, Massachusetts, United States.
How many employees does Lifeward have?
Lifeward has about 80 employees.
Has Lifeward raised funding?
Yes. Fundz has recorded 5 funding events for Lifeward. The most recent, $11.2M, was in Jul 2026.
What is the latest news on Lifeward?
On Oct 27, 2026, Lifeward Ltd. Appoints Ronen Tsimerman as Chief Financial Officer
Is Lifeward a public company?
Yes. Lifeward is publicly traded under the ticker LFWD.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy